AOK Chief Carola Reimann warns of a possible financial collapse caused by the costs of weight loss injections for severe obesity, which could reach up to 45 billion euros annually if covered for all insured individuals with a BMI over 30, while her argument is challenged by the fact that effective therapies could help reduce the existing billion-dollar costs associated with obesity-related health issues. (translated)



